Alucent Biomedical logo

Alucent Biomedical Funding & Investors

Salt Lake City, UT

Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency. The therapy focuses on peripheral artery disease (PAD), arteriovenous fistula (AVF) maturation for dialysis, and more.

alucentmedical.com

Total Amount Raised: $46,600,000

Alucent Biomedical Funding Rounds

  • Series Unknown

    $11,200,000

  • Series B

    $34,999,999

  • Seed

    $400,000

Funding info provided by Diffbot.